• Seer filed a patent infringement lawsuit against Nanomics over nanoparticle protein enrichment technology used in Nanomics’ Proteonano kits and workstations.
• Suit asserts multiple Seer patents, including U.S. Patent No. 11,435,360, covering nano- and micro-particle protein enrichment; Brigham and Women’s Hospital is joining case.
• Seer is seeking monetary damages plus injunctive relief.
• Company cited a March 23 Patent Trial and Appeal Board final written decision in an inter partes review that upheld key claims in U.S. Patent No. 11,435,360.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seer Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605130700PRIMZONEFULLFEED9719160) on May 13, 2026, and is solely responsible for the information contained therein.